Long-Awaited Risk Assessment Commission Finally Ready To Convene

The 10-member RAMC is charged with evaluating current standards and methods of assessing environmental hazards and recommending how that information should be used in regulating toxic substances. Government officials, environmental scientists, and others associated with the field expect the commission's deliberations to have significant implications for researchers and regulators who evaluate and attempt to mediate the dangers posed

Written byKaren Kreeger
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The 10-member RAMC is charged with evaluating current standards and methods of assessing environmental hazards and recommending how that information should be used in regulating toxic substances. Government officials, environmental scientists, and others associated with the field expect the commission's deliberations to have significant implications for researchers and regulators who evaluate and attempt to mediate the dangers posed by environmental hazards.

Risk assessment entails characterizing and quantifying the potential harmful effects of environmental toxins on humans, environmental scientists point out. Risk management, meanwhile, adds socioeconomic factors--such as costs and potential job losses--into the process of regulating such toxins (see story on page 4). As part of its mandate, the commission will take into consideration, among other things, a recently published report from the National Academy of Sciences' (NAS) National Research Council (NRC) addressing risk-assessment issues.

Carl Mazza, a science adviser in the Environmental Protection Agency (EPA) office of air and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies